Skip to main content

Travis Osterman Archives

Targeted cancer drug during pregnancy

Aug. 2, 2022—The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.

Read more


Osterman plays key role in major oncology EHR initiative

Feb. 3, 2022—Vanderbilt's Travis Osterman, DO, MS, is leading an integral component of the Minimal Common Data Elements (mCODE) initiative, establishing common data standards for oncology clinicians and researchers.

Read more


VUMC’s Osterman awarded Microsoft Investigator Fellowship

Nov. 7, 2019—Travis Osterman, DO, MS, has been awarded a Microsoft Investigator Fellowship.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more